# \[e-med\] Expliquer la bonne observance aux traitements ARV en Afrique sub-saharienne : une étude ethnographique

**URL:** <https://talk.edrugplus.org/t/e-med-expliquer-la-bonne-observance-aux-traitements-arv-en-afrique-sub-saharienne-une-etude-ethnographique/31235>\
**Category:** e-med\
**Created:** [February 3, 2009, 9:52am UTC](https://talk.edrugplus.org/t/e-med-expliquer-la-bonne-observance-aux-traitements-arv-en-afrique-sub-saharienne-une-etude-ethnographique/31235 "2009-02-03T09:52:28Z")\
**Posts on this page:** 1\
**Page:** 1

<div class="post-metadata">

**Author:** ![remed9](https://avatars.discourse-cdn.com/v4/letter/r/22d042/32.png) [@remed9](https://talk.edrugplus.org/u/remed9)\
**Post date:** [February 3, 2009, 9:52am UTC](https://talk.edrugplus.org/t/e-med-expliquer-la-bonne-observance-aux-traitements-arv-en-afrique-sub-saharienne-une-etude-ethnographique/31235/1 "2009-02-03T09:52:28Z")

</div>

[article en entier disponible :  
[http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/](http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/)  
journal.pmed.1000011  
CB]

Résumé

Explaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study

Norma C. Ware1\*, John Idoko2, Sylvia Kaaya3, Irene Andia Biraro4, Monique A.  
Wyatt1, Oche Agbaji2, Guerino Chalamilla5,6, David R. Bangsberg1,7,8

1 Harvard Medical School, Boston, Massachusetts, United States of America, 2  
Jos University, Jos, Nigeria, 3 Muhimbili University of Health and Allied  
Sciences, Dar es Salaam, Tanzania, 4 Mbarara University of Science and  
Technology, Mbarara, Uganda, 5 Muhimbili University/Dar es Salaam City  
Council/Harvard School of Public Health HIV/AIDS Care and Treatment Program,  
Dar es Salaam, Tanzania, 6 Harvard School of Public Health, Boston,  
Massachusetts, United States of America, 7 Massachusetts General Hospital,  
Boston, Massachusetts, United States of America, 8 Harvard Initiative for  
Global Health, Cambridge, Massachusetts, United States of America

Background

Individuals living with HIV/AIDS in sub-Saharan Africa generally take more  
than 90% of prescribed doses of antiretroviral therapy (ART). This number  
exceeds the levels of adherence observed in North America and dispels early  
scale-up concerns that adherence would be inadequate in settings of extreme  
poverty. This paper offers an explanation and theoretical model of ART  
adherence success based on the results of an ethnographic study in three  
sub-Saharan African countries.

Methods and Findings

Determinants of ART adherence for HIV-infected persons in sub-Saharan Africa  
were examined with ethnographic research methods. 414 in-person interviews  
were carried out with 252 persons taking ART, their treatment partners, and  
health care professionals at HIV treatment sites in Jos, Nigeria; Dar es  
Salaam, Tanzania; and Mbarara, Uganda. 136 field observations of clinic  
activities were also conducted. Data were examined using category  
construction and interpretive approaches to analysis. Findings indicate that  
individuals taking ART routinely overcome economic obstacles to ART  
adherence through a number of deliberate strategies aimed at prioritizing  
adherence: borrowing and begging transport funds, making impossible  
choices to allocate resources in favor of treatment, and doing without.  
Prioritization of adherence is accomplished through resources and help made  
available by treatment partners, other family members and friends, and  
health care providers. Helpers expect adherence and make their expectations  
known, creating a responsibility on the part of patients to adhere. Patients  
adhere to promote good will on the part of helpers, thereby ensuring help  
will be available when future needs arise.

Conclusion

Adherence success in sub-Saharan Africa can be explained as a means of  
fulfilling social responsibilities and thus preserving social capital in  
essential relationships.

Funding: This study was supported by grants from the U.S. National Institute  
of Mental Health (NIMH, R21 MH077539, MH54907) and the Harvard University  
Program on AIDS. DRB was funded by a grant from the National Institute of  
Alcohol and Alcoholism (K-24 AA 015287) and the NIMH (MH54907). The funders  
played no role in the design or conduct of the research, the decision to  
publish, or the preparation of the manuscript.

Competing Interests: The authors have declared that no competing interests  
exist.

Academic Editor: Chris Beyrer, Johns Hopkins University, United States of  
America

Citation: Ware NC, Idoko J, Kaaya S, Biraro IA, Wyatt MA, et al. (2009)  
Explaining Adherence Success in Sub-Saharan Africa: An Ethnographic Study.  
PLoS Med 6(1): e1000011 doi:10.1371/journal.pmed.1000011

Received: June 3, 2008; Accepted: November 19, 2008; Published: January 27,  
2009

Copyright: © 2009 Ware et al. This is an open-access article distributed  
under the terms of the Creative Commons Attribution License, which permits  
unrestricted use, distribution, and reproduction in any medium, provided the  
original author and source are credited.

Abbreviations: ART, antiretroviral therapy

\* To whom correspondence should be addressed. E-mail:  
norma\_ware@hms.harvard.edu
